节点文献

肝门部海绵状血管瘤的动脉栓塞治疗

Treatment of hilar cavernous hemangiomas of the liver by hepatic arterial embolization

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张彦舫冯敢生梁惠民郑传胜窦永充冯晓波

【Author】 ZHANG Yan-fang, FENG Gan-sheng, LIANG Hui-ming, et al. Department of Radiology, the Second Affiliated Hospital, Jinan University School of Medicine, Shenzhen People’s Hospital, Shenzhen 518020, China

【机构】 暨南大学医学院第二附属医院深圳市人民医院放射科华中科技大学同济医学院附属协和医院放射科暨南大学医学院第二附属医院深圳市人民医院放射科湖北省肿瘤医院放射科

【摘要】 目的评价经肝动脉栓塞治疗肝门部附近海绵状血管瘤的疗效和价值。方法14例肝门部海绵状血管瘤使用平阳霉素碘化油乳剂+明胶教海绵颗粒经肝动脉栓塞,术后随访3~36月,观察栓塞前、后瘤体的变化,临床症状缓解情况。结果随访期间,14例临床症状明显缓解,瘤体均有不同程度的缩小,在术后12月CT复查时,瘤体直径由术前7.33±1.8cm缩小至3.5±1.7cm(P<0.05),无严重并发症。结论肝动脉栓塞术是治疗肝门部海绵状血管瘤的首选方法。

【Abstract】 Objective To investigate the therapeutic effects of hepatic arterial embolization for hilar cavernous hemangiomas of the liver. Methods Fourteen cases of hilar cavernous hemangiomas of liver were treated with Pingyangmycin-lipiodol emulsion combined with gelatin particles by transcatheter hepatic arterial embolization. All cases were followed up for 3-36 months after procedures. The changes of cavernous hemangiomas and improvement of clinical signs were observed. Results During the period of follow-up, the cavernous hemangiomas were shrunk to varying agrees and symptoms alleviated in all cases. Twelve months after treatment, the size of cavernous hemangiomas was reduced from ( 7.33± 1.8) cm to ( 3.5± 1.7) cm (P< 0.05). No serious complications occurred. Conclusion Transcatheter hepatic artery embolization with Pingyangmycin-lipiodol emulsion is the first choice for hilar cavernous hemangiomas of the liver.

【基金】 深圳市医学重点学科建设资助
  • 【文献出处】 腹部外科 ,Journal of Abdominal Surgery , 编辑部邮箱 ,2006年03期
  • 【分类号】R735.7
  • 【被引频次】4
  • 【下载频次】37
节点文献中: